Hit Co., Ltd. (TYO:378A)
2,078.00
-34.00 (-1.61%)
Aug 1, 2025, 3:30 PM JST
Ligand Pharmaceuticals Revenue
In the fiscal year ending June 30, 2024, Hit Co., Ltd. had annual revenue of 4.12B JPY with 20.00% growth. Hit Co., Ltd. had revenue of 925.00M in the quarter ending March 31, 2025.
Revenue
4.12B
Revenue Growth
+20.00%
P/S Ratio
3.14
Revenue / Employee
49.66M
Employees
83
Market Cap
12.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.12B | 687.00M | 20.00% |
Jun 30, 2023 | 3.44B | 833.90M | 32.06% |
Jun 30, 2022 | 2.60B | 699.94M | 36.82% |
Jun 30, 2021 | 1.90B | -223.26M | -10.51% |
Jun 30, 2020 | 2.12B | -76.74M | -3.49% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SoftBank Group | 7,243.75B |
NTT, Inc. | 13.70T |
SoftBank | 6,544.35B |
KDDI Corporation | 5,917.95B |
LY Corporation | 1,917.48B |
Toho Co., Ltd. | 312.07B |
Nippon Television Holdings | 461.92B |
TBS Holdings,Inc. | 406.70B |